Riverwater Partners LLC Bristol Myers Squibb CO Transaction History

Riverwater Partners LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 18, 2023	BUY	$57.89 - $64.73 $39,886 - $44,598	689 Added 17.69%	4,583 $265,000
Q2 2023 Jul 18, 2023	SELL	$63.71 - $70.74 $20,387 - $22,636	-320 Reduced 7.59%	3,894 $249,000
Q1 2023 Apr 12, 2023	SELL	$65.71 - $74.53 $5,125 - $5,813	-78 Reduced 1.82%	4,214 $292,000
Q4 2022 Jan 12, 2023	SELL	$68.48 - $81.09 $137,165 - $162,423	-2,003 Reduced 31.82%	4,292 $0
Q3 2022 Nov 08, 2022	BUY	$0.13 - $76.84 $818 - $483,707	6,295 New	6,295 $448,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Riverwater Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Riverwater Partners LLC with notifications on news.